Revised CDC guidelines on opioids are a step in the right direction, but much work remains

Revised CDC guidelines on opioids are a step in the right direction, but much work remains

The recent CDC decision to amend the opioid prescription guidelines comes as a relief to millions of chronic pain patients and practitioners across the US Since the 2016 revisions encouraging doctors to avoid opioids where possible, people with chronic pain have been fighting to get proper access to necessary medicines and doses. While the regulations … Read more

AI to help bridge care gap between visits for high risk patients

AI to help bridge care gap between visits for high risk patients

A lot can happen for patients between provider visits, especially for high-risk patients batting chronic diseases. And amidst a nationwide provider shortage, having the manpower to sort through patients and prioritize those most at risk in the next given 24-48 hours seems unrealistic. Current patient portals offer a reactive option, where patients can reach out … Read more

Despite $ 35 insulin cap being popular, and bipartisan, Congress may not pass it

Despite $ 35 insulin cap being popular, and bipartisan, Congress may not pass it

Democrats in the Senate are primed this month to make their first attempt at salvaging one of the most popular elements of President Joe Biden’s stalled Build Back Better plan – the proposal to cap insulin costs at $ 35 a month. It might not go well. That’s true even though the idea of ​​helping … Read more

Princeton spinout ArrePath gets $ 20M to combine AI, imaging in antibiotics R&D

Princeton spinout ArrePath gets $ 20M to combine AI, imaging in antibiotics R&D

Antibiotic resistance is a growing problem, and it’s one that large pharmaceutical companies have largely abandoned. Some startups are filling the gap, and a new one, ArrePath, has novel molecules with a different approach that could overcome the challenges of drug resistance. The young company has emerged with $ 20 million in seed funding. ArrePath … Read more

Eli Lilly to stand trial over Medicaid rebate payments

Eli Lilly to stand trial over Medicaid rebate payments

A whistleblower complaint against Eli Lilly is now headed to a jury trial. On February 28, Judge Harry D. Leinenweber ruled that the lawsuit against Eli Lilly for allegedly shortchanging the Centers for Medicare and Medicaid Services (CMS) on rebates will proceed to trial, despite Lilly’s request to throw out the case. Monday’s ruling, filed … Read more

Improving the diagnosis and treatment of rare diseases with AI-based technology

Improving the diagnosis and treatment of rare diseases with AI-based technology

To effectively diagnose and treat rare diseases, clinicians and researchers rely on genetic and diagnostic testing as well as phenotypic data to inform their decision-making. For example, a patient’s commonly reported phenotypic data, which include quantified observable traits such as short stature, low-set ears and blood biochemistry, is generally insufficient to yield a definitive diagnosis. … Read more

AI attempts to tackle radiology provider shortage, while also improving outcomes

AI attempts to tackle radiology provider shortage, while also improving outcomes

DiA Imaging Analysis AI-based ultrasound software The American College of Healthcare Executives recently released its survey of the biggest challenges hospitals face with a new concern taking the top spot: labor shortages. Since 2004, the no. 1 concern had been financial challenges. However, labor shortages now snagged the number one spot. And the healthcare labor … Read more

Cancer biotech Rondo gets $ 67M to step on the gas with next-gen bispecific drugs

Cancer biotech Rondo gets $ 67M to step on the gas with next-gen bispecific drugs

The road for any successful drug comes with some wrong turns and detours, so scientists celebrate the successes that come along the way. Nathan Trinklein, co-founder and chief scientific officer of Rondo Therapeutics, remembers one particular success at his previous company. A patient in a clinical trial had a tumor that looked like it was … Read more

CancerIQ raises $ 14M to grow its platform focused on early detection and prevention

CancerIQ raises $ 14M to grow its platform focused on early detection and prevention

CancerIQ announced Thursday that it has raised $ 14 million to grow its precision health platform focused on early cancer detection and prevention. The Chicago-based startup said the funding will also help the company strengthen and broaden its partnerships, including expanding its health system network, as it seeks to eliminate disparities in care. The Series … Read more

Sutter Health chief of digital health shares digital health integration insights

Sutter Health chief of digital health shares digital health integration insights

This interview is part of a series powered by HLTH and CHIME to highlight key insights and perspectives from leading executives speaking at ViVE The pandemic has spurred many hospitals and health systems to rapidly scale virtual health over the past two years, accelerating planned implementation of digital health tools. At the ViVE conference in … Read more